Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. biomarker detection
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Biomarker Detection Articles & Analysis

41 news found

BioMark Receives Funding, Support, Research and Development Project for Cancer Treatment Monitoring

BioMark Receives Funding, Support, Research and Development Project for Cancer Treatment Monitoring

“We are focused on building out our portfolio of assays for early cancer detection and treatment management while maintaining our commitment to continual improvement of our products,” stated Rashid Bux, CEO of BioMark. ...

ByBioMark Diagnostics Inc.


SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

SpinTech CEO Presents STAGE at MedTech Strategist Innovation San Francisco 2021

Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...

BySpinTech, Inc.


Biomark announces update from oongoing clinical trial using its lung cancer liquid biopsy test as it prepares for commercial launch

Biomark announces update from oongoing clinical trial using its lung cancer liquid biopsy test as it prepares for commercial launch

Vancouver, British Columbia – (January 11, 2023) – BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce several updates from ongoing clinical trial ...

ByBioMark Diagnostics Inc.


World Sepsis Day – Raising awareness about one of the most prevalent and deadly, yet misdiagnosed, medical conditions.

World Sepsis Day – Raising awareness about one of the most prevalent and deadly, yet misdiagnosed, medical conditions.

Sepset’s blood-based test works by detecting a unique biomarker signature based on the body’s immune response rather than the presence of a pathogen. ...

BySepset Biosciences Inc.


Optina Diagnostics Earns Frost & Sullivan’s 2022 NA Technology Innovation Leadership Award

Optina Diagnostics Earns Frost & Sullivan’s 2022 NA Technology Innovation Leadership Award

The company is working on an AI-driven Retinal Deep Phenotyping™ solution to detect chronic disease biomarkers, which can enhance the diagnosis of neurodegenerative conditions such as Alzheimer’s. ...

ByOptina Diagnostics


Independent Clinical Study Shows Seravue® Has High Sensitivity And Specificity For The Detection Of Liver Cancer In Nafld And Related Cirrhotic Patients

Independent Clinical Study Shows Seravue® Has High Sensitivity And Specificity For The Detection Of Liver Cancer In Nafld And Related Cirrhotic Patients

This study focused on the performance of Seravue and the LC-SPIK biomarker in detecting hepatocellular carcinoma (HCC) in a pool of nonalcoholic fatty liver disease (NAFLD) related cirrhosis patients. Here, LC-SPIK had an AUC of 0.841 and significantly outperformed AFP, the most common biomarker used for HCC detection today. ...

ByImCare Biotech, LLC


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...

ByAltoida, Inc.


Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

Women’s Brain Project and Altoida Announce Results Highlighting Sex-Based Differences Using Predictive Digital Biomarker in Alzheimer’s Disease

The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...

ByAltoida, Inc.


PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

” Highlights from the first quarter and recent weeks include: The American College of Gastroenterology (“ACG”) updated its clinical guideline for the diagnosis and management of esophageal precancer, endorsing, for the first time, nonendoscopic biomarker screening to detect precancer and prevent highly lethal esophageal cancer, providing ...

ByPAVmed Inc.


Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...

ByOptina Diagnostics


Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis

Biomarker detection can provide insight into the mechanism of action or resistance of new drugs in disease models. Creative Proteomics can provide detection services for cytokines and biomarkers for the majority of pharmaceutical R&D personnel. Its Cytokine division has complete infrastructure and advanced equipment, and ...

ByCreative Proteomics


Comprehensive genomic profiling-informed personalized molecular residual disease detection

Comprehensive genomic profiling-informed personalized molecular residual disease detection

Personalized multiplex PCR was used to detect and evaluate prognostic value of ctDNA from plasma collected at MRD timepoint post-surgery (median 27 days, range 8-99.5). ...

ByFoundation Medicine, Inc.


Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution

Nanox Announces Issuance of American Medical Association New Category III CPT® Code for Its Coronary Artery Calcium Population Health Solution

CAC is a recognized vital biomarker for detection of cardiovascular disease. Nanox.AI believes that early detection and subsequent treatment of cardiovascular disease has the potential to significantly decrease the morbidity and mortality of this highly prevalent condition. ...

ByNano-X Imaging Ltd.


NIAID awards Phase I contract to Kephera Diagnostics for the development of a new test for Chagas disease

NIAID awards Phase I contract to Kephera Diagnostics for the development of a new test for Chagas disease

With the contract funding, Kephera plans to develop a test that will indicate the presence of active T. cruzi infection based on detection of T. cruzi biomarkers in blood samples. The test will be translated into both laboratory-based and point-of-care formats to address the needs of clinical and field settings. ...

ByKephera Diagnostics, LLC


X-ZELL hMX technology now available for research use

X-ZELL hMX technology now available for research use

According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation biomarkers for early cancer detection and has set a new standard for white blood cell depletion from whole blood. ...

ByX-Zell Inc.


X-ZELL launches new Imaging Technology unit

X-ZELL launches new Imaging Technology unit

“In 2017 we developed a platform technology capable of detecting previously undetectable cells in a routine lab,” Dr Bhakdi commented. ...

ByX-Zell Inc.


Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

Does volume matter? Impact of collection volumes on detection of biomarkers and HPV DNA in first-void urine

The results showed that all three different first-void urine collection volumes with Urine Conservation Medium (UCM) allow for biomarker detection. Human Papillomavirus (HPV) can be detected in first-void urine Methods to optimize first-void urine collection Study summary: Impact of different urine volumes on detection of ...

ByOraSure Technologies


FlavourSpec feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

FlavourSpec feasibly detects hepatocellular carcinoma urinary biomarkers in clinical practice

The Imspex Group’s proprietary gas chromatography-ion mobility spectrometry (GC-IMS) technology was part of a ground-breaking cancer detection study that was recently carried out by a team of researchers from the University of Warwick, Coventry University and the University of Leicester. In this study, the FlavourSpec® headspace analysis device showed that volatile organic compounds ...

ByImspex Diagnostics Ltd.


The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

The Netherlands started QIAsure Methylation Test implementation trial for triage of HPV positively screened women

Methylation patterns on the promoter regions of tumor suppressor genes involved in cervical cancer development have demonstrated to be sensitive biomarkers to detect cervical cancer and severe precursor stadia (CIN3+). ...

BySelf-screen B.V.


Unique Metabolic Signatures Associated with Autism Spectrum Disorder (ASD) Detect More than 50% of individuals with ASD in Children’s Autism Metabolome Project (CAMP)

Unique Metabolic Signatures Associated with Autism Spectrum Disorder (ASD) Detect More than 50% of individuals with ASD in Children’s Autism Metabolome Project (CAMP)

Analysis of other potential blood-based biomarkers using CAMP study samples is ongoing. Validation of additional metabotypes of ASD is expected to result in the ability to detect a still higher percentage of children at risk of ASD using this approach. ...

ByNeuroPointDX

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT